Bloodstream Infections in Children with Cancer between 2005 and 2008 in a Single Center |
Kim, Ji Hye
(Department of Pediatrics, Hanyang University School of Medicine)
Kim, Hyung Jin (Department of Pediatrics, Hanyang University School of Medicine) Lim, Yeon Jung (Department of Pediatrics, Hanyang University School of Medicine) Lee, Young Ho (Department of Pediatrics, Hanyang University School of Medicine) Oh, Sung Hee (Department of Pediatrics, Hanyang University School of Medicine) |
1 | Pizzo PA. Evaluation of fever in the patient with cancer. Eur J Cancer Clin Oncol 1989;25 Suppl 2:886-90. |
2 | Mary JF, William AC, Michael ND, George E, David WH, Janet FH, et al. Performance standards for antimicrobial susceptibility testing. Twelfth international supplement. P66-7, villanova, PA, National Committee for Clinical Laboratory Standards 2002. |
3 | Hughes WT, Armstrong D, Bodey GP, Bow EJ, Brown AE, Calandra T, et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002;34:730-51. DOI ScienceOn |
4 | Madani TA. Clnical infections and bloodstream isolates associated with fever in patients undergoing chemotherapy for acute myeloid leukemia. Infection 2000;28: 367-71. DOI ScienceOn |
5 | Gaytan-Martinez J, Mateos-Garcia E, Sanchez-cortes E, Gonzalesz-Llaven J, Casanova-Cardiel LJ, Fuentes- Allen JL. Microbiological findings in febrile neutropenia. Arch Med Res 2000;31:399-94. DOI ScienceOn |
6 | Serody JS. Fever in immunocompromised patients. N Engl J Med 2000;342:217-9. DOI ScienceOn |
7 | Elting L, Rubenstein E, Rolston K, Bodey G. Outcomes of bacteremia in patients with cancer and neutropenia : Observations from two decades of epidemiological and clinical trials. Clin Infect Dis 1997;25:247-59. DOI ScienceOn |
8 | Ariffin H, Navaratnam P, Lin HP. Surveillance study of bacteremic episodes in febrile neutropenic children. Int J Clin Pract 2002;56:237-40. |
9 | Ammann RA, Hirt A, Luthy AR, Aebi C. Predicting bacteremia in children with fever and chemotherapy-induced neutropenia. Pediatr Infect Dis J 2004;23:61-7. DOI ScienceOn |
10 | Carlisle PS, Gucalp R, Wiernik PH. Nosocomial infections in neutropenic cancer patients. Infect Control Hosp Epidemiol 1993;14:320-4. DOI ScienceOn |
11 | Ashkenazi S, Leibovici L, Samra Z, Konisberger H, Drucker M. Risk factors for mortality due to bacteremia and fungemia in childhood. Clin Infect Dis 1992;14:949-51. DOI ScienceOn |
12 | Guven GS, Uzun O, Cakir B, Akova M, Unal S. Infectious complications in patients with hematological malignancies consulted by the infectious disease team: a retrospective cohort study (1997-2001). Support Care Cancer 2006;14:52-5. DOI ScienceOn |
13 | Pizzo PA. Management of fever in patient with cancer and treatment-induced neutropenia. N Engl J Med 1993;328:1323-32. DOI ScienceOn |
14 | De Vita VT Jr, Hellman S, Rosenberg S. Cancer, principles & practice of oncology. 6th edition. Philadelphia (PA): Lippincott Williams % Wilkins Publications; 2001. |
15 | Chaberny IF. Ruseva E, Sohr D, Buchholz S, Ganser A, Mattner F, et al. Surveillance with successful reduction of central line-associated bloodstream infections among neutropenic patients with hematologic or oncologic malignancies. Ann Hematol 2009;88:907-12. DOI ScienceOn |
16 | Mirro J Jr, Rao BN, Stokes DC, Austin BA, Kumar M, Dahl GV, et al. A prospective study of Hickman/Broviac catheters and implantable ports in pediatric oncology patients. J Clin Oncol 1989;7:214-22. DOI |
17 | Viscoli C, Castagnola E, Giacchino M, Cesaro S, Properzi E, Tucci F, et al. Bloodstream infections in children with cancer : a multicentre surveillance study of the Italian Association of Paediatric Haematology and Oncology. Supportive Therapy Group-Infectious Diseases Section. Eur J Cancer 1999;35:770-4. DOI ScienceOn |
18 | Hann I, Viscoli C, Paesmans M, Gaya H, Glauser M. A comparison of outcome from febrile neutropenic episodes in children compared with adults : results from four EORTC studies. International Antimicrobial Therapy Cooperatve Group (IATCG) of the European Organization for Research and Treatment of Cancer (EORTC). Br J Haematol 1997;99:580-8. DOI ScienceOn |
19 | Marena C, Zecca M, Carenini ML, Bruschi A, Bassi ML, Olivieri P, et al. Incidence of, and risk factors for, nosocomial infections among hematopoietic stem cell transplantation recipients, with impact on procedure-related mortality. Infect Control Hosp Epidemiol 2001;22: 510-7. DOI ScienceOn |
20 | Ingram J, Weitzman S, Greenberg ML, Parkin P, Filler R. Complications of indwelling venous access lines in the pediatric hematology patient : a prospective comparison of external venous catheters and subcutaneous ports. Am J Pediatr Hematol Oncol 1991;13:130-6. DOI |
21 | Mueller BU, Skelton J, Callender DP, Marshall D, Gress J, Longo D, et al. A prospective randomized trial comparing the infectious and noninfectious complications of an externalized catheter versus a subcutaneously implanted device in cancer patients. J Clin Oncol 1992;12: 1943-8. |
22 | Hengartner H, Berger C, Nadal D, Niggli FK, Grotzer MA. Port-A-Cath infections in children with cancer. Eur J Cancer 2004;40:2452-8. DOI ScienceOn |
23 | Sheretz RJ, Raad II, Balani A, Koo L, Rand K. Threeyear experience with sonicated vascular catheter cultures in a clinical microbiology laboratory. J Clin Microbiol 1990;28:76-82. |
24 | Richards MJ, Edwards JR, Culver DH, Gaynes RP. Nosocomial bloodstream infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit Care Med 1997;27:887- 92. |
25 | Raad II. Intravascular-catheter-related infections. Lancet 1998;351:894-98. |
26 | Raad II, Darouiche RO. Catheter-related septicemia : risk reduction. Infect Med 1996;13:807-12. |
27 | Choi EH, Pyo JW, Park JY, Kwon KB, Yun BY, Shin HY, et al. Infections in children with neoplastic disease. J Korean Pediatr Soc 1995;38:366-77. |
28 | Yun BY, Lee HJ. Septicemia in children with neoplastic disease. J Korean Pediatr Soc 1992;35:1481-91. |
29 | Kim YH, Lee HD, Hah JO. Bacteremia in pediatric cancer patients: causative organisms and antibiotic sensitivities. Korean J Pediatr 2005;48:619-23. |
30 | Park SM, Choe BK, Kim CS, Kim JS, Kim HS, Ryoo NH. Bacteremia in pediatric cancer patients: a single center study. Korean J Pediatr 2006;49:882-8. DOI |
31 | Park HW, Youn HS, Im HJ, Kim MN, Seo JJ, Moon HN. Risk factors of bloodstream infection associated mortality in pediatric patients with hemato-oncologic disease. Korean J Hematol 2007;42:343-52. DOI ScienceOn |
32 | Urrea M, Rives S, Cruz O, Navarro A, Garcia JJ, Estella J. Nosocoial infections among pediatric hematology/ oncology patients: Results of a prospective incidence study. Am J Infect Control 2004;32:205-8. DOI ScienceOn |
33 | Simon A, Fleischhack G, Hassan C, Bode U, Engelhart S, Kramer M. Surveillance for nosocomial and central line related infections among pediatric hematologyoncology patients. Infect Control Hosp Epidemiol 2000;21:592-6. DOI ScienceOn |
34 | Wisplinghoff H, Seifert H, Wenzel RP, Edmond MB. Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States. Clin Infect Dis 2003;36:1103-10. DOI ScienceOn |
35 | Zinner SH, Changing epidemiology of infections in patients with neutropenia and cancer : emphasis on gram positive and resistant bacteria. Clin Infect Dis 1999;29: 490-4. DOI ScienceOn |
36 | Collin BA, Leather HL, Wingard JR, Ramhal R. Evolution, incidence, and susceptibility of bacterial bloodstream isolates from 519 bone marrow transplant patients. Clin Infect Dis 2001;33:947-53. DOI ScienceOn |
37 | Edmond MB, Wallace SE, McClish DK, Pfaller MA, Jones RN, Wenzel RP. Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis 1999;29:239-44. DOI ScienceOn |
38 | Kim SH, Lee YA, Eun BW, Kim NH, Lee JA, Kang HJ, et al. Etiological agents isolated from blood in children with hemato-oncologic diseases (2002-2005). Korean J Pediatr 2007;50:56-64. DOI ScienceOn |